Events & Training

ADMET 2018

09 July 2018 - 10 July 2018

SMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th - 10th July 2018. Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost, and minimise production times. The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.

Holiday Inn, Kensington Forum, London, UK